ORMP - Oramed Pharmaceuticals to join Russell 2000 and 3000 Index

A clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, Oramed Pharmaceuticals (ORMP) set to join the U.S. small cap Russell 2000 and broad-market Russell 3000 Index at annual reconstitution, effective June 28, 2021.Membership in the U.S. all-cap Russell 3000 Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000 Index or small-cap Russell 2000 Index as well as the appropriate growth and value style indexes.

For further details see:

Oramed Pharmaceuticals to join Russell 2000 and 3000 Index